Litcius/Paper detail

Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma

Dávid Kegyes, Diana Gulei, Rareş Drulă, Diana Cenariu, Adrian Bogdan Țigu, Delia Dima, Alina Tănase, Sorina Bădeliță, Anca Dana Buzoianu, Stefan O. Ciurea, Gabriel Ghiaur, Evangelos Terpos, Aaron Ciechanover, Hermann Einsele, Ciprian Tomuleasa

2023Blood Reviews17 citationsDOI

Topics & Concepts

CarfilzomibMultiple myelomaBortezomibIxazomibMedicineProteasomeProteasome inhibitorImmunotherapyMonoclonal antibodyCancer researchPlasma cellDrugAntibodyPharmacologyImmunologyOncologyImmune systemChemistryBiochemistryMultiple Myeloma Research and TreatmentsUbiquitin and proteasome pathwaysProtein Degradation and Inhibitors
Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma | Litcius